To further confirm that SRSF1-knockdown could inhibit Gefitinib-resistant cancer cell progression through activation of autophagy, we knocked down ATG5, a factor required for autophagic vesicle formation,49 in SRSF1-reduced Gefitinib-resistant HCC827 cells (Fig. 7i). The gene discussed is ATG5; the disease is cancer.